Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study)

This multicentre, prospective, randomized, open‐label, blinded‐endpoint, parallel‐group, short‐term (4–5 weeks) controlled trial was conducted to investigate the superiority of the effect of reducing mean amplitude of glycaemic excursions (MAGE) during meal tolerance tests (MTTs) for the combination...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Diabetes Obes Metab
Main Authors: Cho, Kyu Yong, Nomoto, Hiroshi, Nakamura, Akinobu, Kawata, Shinichiro, Sugawara, Hajime, Takeuchi, Jun, Nagai, So, Tsuchida, Kazuhisa, Omori, Kazuno, Yokoyama, Hiroki, Manda, Naoki, Kurihara, Yoshio, Aoki, Shin, Atsumi, Tatsuya, Miyoshi, Hideaki
פורמט: Artigo
שפה:Inglês
יצא לאור: Blackwell Publishing Ltd 2019
נושאים:
Brief Reports
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7065098/
https://ncbi.nlm.nih.gov/pubmed/31486230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13879
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים